StreetInsider.com News Articles

StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 15 Jul 2024 07:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday LSL Pharma Group Announces Closing of Second and Final Tranche of Private Placement and Closing of Units for Debt http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html <p align="justify">BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=d17wbOABGl_iQn5P_T0PX0vZ_dOUcSDM5qNeb8tKodSzrqTKMxgrydpxdeY06Pvo8_Jg0mIZUDfke7YfBBgNKuS1S8ipIT4GzEZ2_zMvcPc=" rel="nofollow" target="_blank">LSL PHARMA GROUP INC</a>. (TSXV: LSL) (the "<strong>Corporation</strong>" or "<strong>LSL Pharma</strong> "), a Canadian integrated pharmaceutical company, is pleased to announce that it closed on July 12, 2024, the second and last tranche of a non-brokered private placement (the “<strong>Financing</strong>”) consisting of 2,400,000 units (each, a “<strong>Unit</strong>”) at a price of $0.40 per Unit for total gross proceeds of $960,000. Each Unit consists of one class A share of the Corporation (a “<strong>Common Share</strong>”) and one Common Share purchase warrant (a “<strong>Warrant</strong>”). Each Warrant entitles http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html Mon, 15 Jul 2024 07:00:00 -0400 A.36078215 LSL O.00783833 O.10492747 LSL Pharma Group Announces Closing of Second and Final Tranche of Private Placement and Closing of Units for Debt http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html <p align="justify">BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=d17wbOABGl_iQn5P_T0PX0vZ_dOUcSDM5qNeb8tKodSzrqTKMxgrydpxdeY06Pvo8_Jg0mIZUDfke7YfBBgNKuS1S8ipIT4GzEZ2_zMvcPc=" rel="nofollow" target="_blank">LSL PHARMA GROUP INC</a>. (TSXV: LSL) (the "<strong>Corporation</strong>" or "<strong>LSL Pharma</strong> "), a Canadian integrated pharmaceutical company, is pleased to announce that it closed on July 12, 2024, the second and last tranche of a non-brokered private placement (the “<strong>Financing</strong>”) consisting of 2,400,000 units (each, a “<strong>Unit</strong>”) at a price of $0.40 per Unit for total gross proceeds of $960,000. Each Unit consists of one class A share of the Corporation (a “<strong>Common Share</strong>”) and one Common Share purchase warrant (a “<strong>Warrant</strong>”). Each Warrant entitles http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html Mon, 15 Jul 2024 07:00:00 -0400 A.36078215 LSL O.00783833 O.10492747 LSL Pharma Group Announces Closing of Second and Final Tranche of Private Placement and Closing of Units for Debt http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html <p align="justify">BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=d17wbOABGl_iQn5P_T0PX0vZ_dOUcSDM5qNeb8tKodSzrqTKMxgrydpxdeY06Pvo8_Jg0mIZUDfke7YfBBgNKuS1S8ipIT4GzEZ2_zMvcPc=" rel="nofollow" target="_blank">LSL PHARMA GROUP INC</a>. (TSXV: LSL) (the "<strong>Corporation</strong>" or "<strong>LSL Pharma</strong> "), a Canadian integrated pharmaceutical company, is pleased to announce that it closed on July 12, 2024, the second and last tranche of a non-brokered private placement (the “<strong>Financing</strong>”) consisting of 2,400,000 units (each, a “<strong>Unit</strong>”) at a price of $0.40 per Unit for total gross proceeds of $960,000. Each Unit consists of one class A share of the Corporation (a “<strong>Common Share</strong>”) and one Common Share purchase warrant (a “<strong>Warrant</strong>”). Each Warrant entitles http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html Mon, 15 Jul 2024 07:00:00 -0400 A.36078215 LSL O.00783833 O.10492747 LSL Pharma Group Announces Closing of Second and Final Tranche of Private Placement and Closing of Units for Debt http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html <p align="justify">BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=d17wbOABGl_iQn5P_T0PX0vZ_dOUcSDM5qNeb8tKodSzrqTKMxgrydpxdeY06Pvo8_Jg0mIZUDfke7YfBBgNKuS1S8ipIT4GzEZ2_zMvcPc=" rel="nofollow" target="_blank">LSL PHARMA GROUP INC</a>. (TSXV: LSL) (the "<strong>Corporation</strong>" or "<strong>LSL Pharma</strong> "), a Canadian integrated pharmaceutical company, is pleased to announce that it closed on July 12, 2024, the second and last tranche of a non-brokered private placement (the “<strong>Financing</strong>”) consisting of 2,400,000 units (each, a “<strong>Unit</strong>”) at a price of $0.40 per Unit for total gross proceeds of $960,000. Each Unit consists of one class A share of the Corporation (a “<strong>Common Share</strong>”) and one Common Share purchase warrant (a “<strong>Warrant</strong>”). Each Warrant entitles http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html Mon, 15 Jul 2024 07:00:00 -0400 A.36078215 LSL O.00783833 O.10492747 LSL Pharma Group Announces Closing of Second and Final Tranche of Private Placement and Closing of Units for Debt http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html <p align="justify">BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=d17wbOABGl_iQn5P_T0PX0vZ_dOUcSDM5qNeb8tKodSzrqTKMxgrydpxdeY06Pvo8_Jg0mIZUDfke7YfBBgNKuS1S8ipIT4GzEZ2_zMvcPc=" rel="nofollow" target="_blank">LSL PHARMA GROUP INC</a>. (TSXV: LSL) (the "<strong>Corporation</strong>" or "<strong>LSL Pharma</strong> "), a Canadian integrated pharmaceutical company, is pleased to announce that it closed on July 12, 2024, the second and last tranche of a non-brokered private placement (the “<strong>Financing</strong>”) consisting of 2,400,000 units (each, a “<strong>Unit</strong>”) at a price of $0.40 per Unit for total gross proceeds of $960,000. Each Unit consists of one class A share of the Corporation (a “<strong>Common Share</strong>”) and one Common Share purchase warrant (a “<strong>Warrant</strong>”). Each Warrant entitles http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html Mon, 15 Jul 2024 07:00:00 -0400 A.36078215 LSL O.00783833 O.10492747 LSL Pharma Group Announces Closing of Second and Final Tranche of Private Placement and Closing of Units for Debt http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html <p align="justify">BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=d17wbOABGl_iQn5P_T0PX0vZ_dOUcSDM5qNeb8tKodSzrqTKMxgrydpxdeY06Pvo8_Jg0mIZUDfke7YfBBgNKuS1S8ipIT4GzEZ2_zMvcPc=" rel="nofollow" target="_blank">LSL PHARMA GROUP INC</a>. (TSXV: LSL) (the "<strong>Corporation</strong>" or "<strong>LSL Pharma</strong> "), a Canadian integrated pharmaceutical company, is pleased to announce that it closed on July 12, 2024, the second and last tranche of a non-brokered private placement (the “<strong>Financing</strong>”) consisting of 2,400,000 units (each, a “<strong>Unit</strong>”) at a price of $0.40 per Unit for total gross proceeds of $960,000. Each Unit consists of one class A share of the Corporation (a “<strong>Common Share</strong>”) and one Common Share purchase warrant (a “<strong>Warrant</strong>”). Each Warrant entitles http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html Mon, 15 Jul 2024 07:00:00 -0400 A.36078215 LSL O.00783833 O.10492747 LSL Pharma Group Announces Closing of Second and Final Tranche of Private Placement and Closing of Units for Debt http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html <p align="justify">BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=d17wbOABGl_iQn5P_T0PX0vZ_dOUcSDM5qNeb8tKodSzrqTKMxgrydpxdeY06Pvo8_Jg0mIZUDfke7YfBBgNKuS1S8ipIT4GzEZ2_zMvcPc=" rel="nofollow" target="_blank">LSL PHARMA GROUP INC</a>. (TSXV: LSL) (the "<strong>Corporation</strong>" or "<strong>LSL Pharma</strong> "), a Canadian integrated pharmaceutical company, is pleased to announce that it closed on July 12, 2024, the second and last tranche of a non-brokered private placement (the “<strong>Financing</strong>”) consisting of 2,400,000 units (each, a “<strong>Unit</strong>”) at a price of $0.40 per Unit for total gross proceeds of $960,000. Each Unit consists of one class A share of the Corporation (a “<strong>Common Share</strong>”) and one Common Share purchase warrant (a “<strong>Warrant</strong>”). Each Warrant entitles http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html Mon, 15 Jul 2024 07:00:00 -0400 A.36078215 LSL O.00783833 O.10492747 LSL Pharma Group Announces Closing of Second and Final Tranche of Private Placement and Closing of Units for Debt http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html <p align="justify">BOUCHERVILLE, Quebec, July 15, 2024 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=d17wbOABGl_iQn5P_T0PX0vZ_dOUcSDM5qNeb8tKodSzrqTKMxgrydpxdeY06Pvo8_Jg0mIZUDfke7YfBBgNKuS1S8ipIT4GzEZ2_zMvcPc=" rel="nofollow" target="_blank">LSL PHARMA GROUP INC</a>. (TSXV: LSL) (the "<strong>Corporation</strong>" or "<strong>LSL Pharma</strong> "), a Canadian integrated pharmaceutical company, is pleased to announce that it closed on July 12, 2024, the second and last tranche of a non-brokered private placement (the “<strong>Financing</strong>”) consisting of 2,400,000 units (each, a “<strong>Unit</strong>”) at a price of $0.40 per Unit for total gross proceeds of $960,000. Each Unit consists of one class A share of the Corporation (a “<strong>Common Share</strong>”) and one Common Share purchase warrant (a “<strong>Warrant</strong>”). Each Warrant entitles http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Closing+of+Second+and+Final+Tranche+of+Private+Placement+and+Closing+of+Units+for+Debt/23461886.html Mon, 15 Jul 2024 07:00:00 -0400 A.36078215 LSL O.00783833 O.10492747 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Press+Releases/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419 LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html <p align="justify">BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- <strong>LSL PHARMA GROUP INC. </strong>(TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held today in Montréal, Québec (the “Meeting”).<br/></p> <p align="justify">The shareholders approved, by a majority of votes, resolutions to elect each of the following directors:</p> <p align="justify" style="padding-left:360px;">Diane Beaudry <br/>Frank J. DellaFera <br/>Stuart W. Fowler <br/>Pierre Lafrenière<br/>Mario Paradis <br/>François Roberge<br/>Joseph Soccodato</p> http://www.streetinsider.com/Globe+Newswire/LSL+Pharma+Group+Announces+Voting+Results+of+Its++Annual+and+Special+Meeting+of+Shareholders/23416265.html Fri, 28 Jun 2024 17:37:00 -0400 A.21388897 A.22583700 A.23054061 A.36078215 LSL O.00783833 O.02094512 O.10492747 O.34267266 O.48400419